Prevalence of Immunosuppressive Drug Use Among Commercially Insured US Adults, 2018-2019

This cross-sectional study uses direct pharmaceutical claims data from a commercial claims database to assess the use of 6 types of immunosuppressive drugs among commercially insured US adults in 2018 and 2019.

Detalles Bibliográficos
Autores principales: Wallace, Beth I., Kenney, Brooke, Malani, Preeti N., Clauw, Daniel J., Nallamothu, Brahmajee K., Waljee, Akbar K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138687/
https://www.ncbi.nlm.nih.gov/pubmed/34014329
http://dx.doi.org/10.1001/jamanetworkopen.2021.4920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8138687/
https://www.ncbi.nlm.nih.gov/pubmed/34014329
http://dx.doi.org/10.1001/jamanetworkopen.2021.4920

Ejemplares similares